WEKO3
アイテム
Multicenter Study of Carbon-Ion Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN)
https://repo.qst.go.jp/records/48554
https://repo.qst.go.jp/records/48554c7878140-9c77-4d79-8da2-09704132d8ba
| Item type | 学術雑誌論文 / Journal Article(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2018-03-05 | |||||
| タイトル | ||||||
| タイトル | Multicenter Study of Carbon-Ion Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN) | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | journal article | |||||
| アクセス権 | ||||||
| アクセス権 | metadata only access | |||||
| アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
| 著者 |
Shazrina, Sulaiman
× Shazrina, Sulaiman× Nor× Demizu, Yuusuke× Koto, Masashi× Saitou, Jyunnichi× Suefuji, Hiroaki× Tsuji, Hiroshi× Ohno, Tatsuya× Shioyama, Yoshiyuki× Okimoto, Tomoaki× Daimon, Takashi× Nemoto, Kenji× Nakano, Takashi× Kamada, Tadashi× 出水 祐介× 小藤 昌志× 齋藤 淳一× 末藤 大明× 辻 比呂志× 大野 達也× 塩山 善之× 沖本 智昭× 根本 建二× 中野 隆史× 鎌田 正 |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Summary Adenoid cystic carcinomas of the head and neck are rare, comparatively radioresistant tumors. In this large cohort of a retrospective multicenter study, we evaluated the effectiveness and safety of carbon-ion radiation therapy in 289 patients with adenoid cystic carcinoma of the head and neck. The physical and biological characteristics of carbon-ions allowed delivery of localized high tumor doses, resulting in good local control and overall survival with tolerable treatmentrelated toxicity. \nPurpose: To retrospectively analyze the treatment outcomes of carbon-ion radiation therapy for adenoid cystic carcinoma (ACC) of the head and neck at 4 active carbon-ion facilities in Japan. Methods and Materials: A total of 289 patients who underwent carbon-ion radiation therapy for histology-proven ACC of the head and neck at 4 institutions in Japan between November 2003 and December 2014 were included in this study. Results: Median patient age was 58 years (range, 12-83 years). Tumor sites included the nasal cavity and paranasal sinuses (42%), nasopharynx and oropharynx (19%), oral cavity (12%), major salivary glands (12%), and others (15%). Tumor classifications were T4 in 200 (69%) patients, T3 in 45 (16%), T2 in 22 (8%), T1 in 15 (5%), and unclassified in 7 (2%). The median total dose was 64 Gy (relative biological effectiveness [RBE]; range, 55.2-70.4 Gy [RBE]) in 16 fractions (range, 12-32 fractions). Median follow-up time was 30 months (range, 2-118 months). The 2-year overall survival, progression-free survival, and local control rates were 94%, 68%, and 88%, respectively. Estimated 5-year overall survival, progression-free survival, and local control rates were 74%, 44%, and 68%, respectively. In all, 43 patients (15%) experienced grade 3 late toxicity, of which osteonecrosis of the jaw bone was the most common. Two patients treated for nasopharyngeal ACC died from a bleeding ulcer at the tumor site (grade 5 toxicity). Conclusions: Carbon-ion radiation therapy seems to be a promising treatment for ACC of the head and neck. 2017 Elsevier Inc. All rights reserved. |
|||||
| 書誌情報 |
International Journal of Radiation Oncology Biology Physics 巻 100, 号 3, p. 639-646, 発行日 2018-02 |
|||||
| 出版者 | ||||||
| 出版者 | Elsevier Inc. | |||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 0360-3016 | |||||
| DOI | ||||||
| 識別子タイプ | DOI | |||||
| 関連識別子 | 10.1016/j.ijrobp.2017.11.010 | |||||
| 関連サイト | ||||||
| 識別子タイプ | DOI | |||||
| 関連識別子 | https://doi.org/10.1016/j.ijrobp.2017.11.010 | |||||
| 関連名称 | https://doi.org/10.1016/j.ijrobp.2017.11.010 | |||||
